Precision oncology: separating the wheat from the chaff

被引：31
|
作者：
Remon, Jordi [1 ]
Dienstmann, Rodrigo [2 ]
机构：
[1] HM Delfos, Ctr Integral Oncol Clara Campal Barcelona, Med Oncol Dept, Barcelona, Spain
[2] Hosp Valle De Hebron, Oncol Data Sci ODysSey Grp, Barcelona, Spain
来源：
ESMO OPEN | 2018年 / 3卷 / 06期
关键词：
CELL LUNG-CANCER; METASTATIC BREAST-CANCER; OPEN-LABEL; MOLECULAR CHARACTERIZATION; ANTICANCER DRUGS; TARGETED THERAPY; FDA APPROVAL; SOLID TUMORS; PHASE-II; MEDICINE;
D O I：
10.1136/esmoopen-2018-000446
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Precision oncology based on next-generation sequencing (NGS) test is growing in daily clinical practice. However, the real impact of this strategy in patients' outcome on a large scale remains uncertain. In this review, we summarise existing literature on this topic, limitations for broad NGS implementation, bottlenecks in genomic variant interpretation and the role of molecular tumour boards.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Recent Advancements and Innovations in Pediatric Precision Oncology
    Mangum, Ross
    Lin, Frank Y.
    Parsons, D. Williams
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (05) : 262 - 271
  • [42] Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
    Tomczak, Aurelie
    Springfeld, Christoph
    Dill, Michael T.
    Chang, De-Hua
    Kazdal, Daniel
    Wagner, Ursula
    Mehrabi, Arianeb
    Brockschmidt, Antje
    Luedde, Tom
    Naumann, Patrick
    Stenzinger, Albrecht
    Schirmacher, Peter
    Longerich, Thomas
    BRITISH JOURNAL OF CANCER, 2022, 127 (09) : 1701 - 1708
  • [43] The importance of precision medicine in modern molecular oncology
    Wang, Yuanli
    Zheng, Dawu
    CLINICAL GENETICS, 2021, 100 (03) : 248 - 257
  • [44] Pioneering the implementation of a precision oncology strategy in Portugal: the Precision Oncology Platform trial
    Mainoli, Beatrice
    Assis, Joana
    Dinis, Jose
    Henrique, Rui
    Oliveira, Julio
    ACTA ONCOLOGICA, 2024, 63 : 482 - 486
  • [45] An Emerging Role for Radiation Oncology in Precision Oncology
    Goyal, Sharad
    Haffty, Bruce G.
    EBIOMEDICINE, 2016, 5 : 9 - 9
  • [46] Precision oncology using ex vivo technology: a step towards individualised cancer care?
    Williams, Sophie T.
    Wells, Greg
    Conroy, Samantha
    Gagg, Hannah
    Allen, Richard
    Rominiyi, Ola
    Helleday, Thomas
    Hullock, Katie
    Pennington, Catherine E. W.
    Rantala, Juha
    Collis, Spencer J.
    Danson, Sarah J.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2022, 24
  • [47] Enabling Precision Oncology Through Precision Diagnostics
    Brown, Noah A.
    Elenitoba-Johnson, Kojo S. J.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 15, 2020, 2020, 15 : 97 - 121
  • [48] Precision medicine in medical oncology: hope, disappointment and reality
    Bartouskova, Marie
    Melichar, Bohuslav
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (09) : 1427 - 1431
  • [49] The NCI-MATCH trial: lessons for precision oncology
    O'Dwyer, Peter J.
    Gray, Robert J.
    Flaherty, Keith T.
    Chen, Alice P.
    Li, Shuli
    Wang, Victoria
    McShane, Lisa M.
    Patton, David R.
    Tricoli, James V.
    Williams, P. Mickey
    Iafrate, A. John
    Sklar, Jeffrey
    Mitchell, Edith P.
    Takebe, Naoko
    Sims, David J.
    Coffey, Brent
    Fu, Tony
    Routbort, Mark
    Rubinstein, Larry V.
    Little, Richard F.
    Arteaga, Carlos L.
    Marinucci, Donna
    Hamilton, Stanley R.
    Conley, Barbara A.
    Harris, Lyndsay N.
    Doroshow, James H.
    NATURE MEDICINE, 2023, 29 (6) : 1349 - 1357
  • [50] Targeted treatment of solid tumors in pediatric precision oncology
    Bertacca, Ilaria
    Pegoraro, Francesco
    Tondo, Annalisa
    Favre, Claudio
    FRONTIERS IN ONCOLOGY, 2023, 13
12345